1Preface
1424.7 Exercise
2Chapter
143Chapter
31 Approach to the Intensive Care Unit (ICU)
1445 Environmental Disorders
41.1 What Is an ICU?
1455.1 BURNS
51.1.1 Historical Development of the ICU
1465.1.1 Pathophysiology
61.1.2 Economical Impact of the ICU
1475.1.2 Predisposition
71.1.3 Organization of the ICU
1485.1.3 Clinical Presentation
81.2 Team Work
1495.1.4 Complications
91.3 The Flowchart
1505.1.5 Treatment
101.4 The Critically Ill Patient
1515.2 Decompression Illness And Air Embolism
111.5 System-Oriented Rounds
1525.2.1 Pathophysiology
121.5.1 Identification
1535.2.2 Predisposition
131.5.2 Major Events over the Last 24 h
1545.2.3 Clinical Presentation
141.5.3 Systems Review
1555.2.4 Complications
151.6 Exercise
1565.2.5 Treatment
16Chapter
1575.3 Near-Drowning
172 The Basics of Critical Care
1585.3.1 Pathophysiology
182.1 Introduction
1595.3.2 Predisposition
192.2 Cardiac Arrest and Resuscitation
1605.3.3 Clinical Presentation
202.2.1 Etiology
1615.3.4 Complications
212.2.2 Pathogenesis
1625.3.5 Admission Criteria
222.2.3 Diagnosis
1635.3.6 Treatment
232.2.4 Differential Diagnosis
1645.3.7 Prognosis
242.2.5 Management
1655.4 Electrical Injuries
252.3 The Alveolar Air Equation
1665.4.1 Pathophysiology
262.4 Oxygen Transport
1675.4.2 Predisposition
272.5 Mechanical Ventilation
1685.4.3 Clinical Presentation
282.5.1 Ventilation
1695.4.4 Complications
292.5.2 Oxygenation
1705.4.5 Treatment
302.5.3 PEEP and Compliance
1715.5 Heat Exhaustion And Heat Stroke
312.5.4 Modes of Mechanical Ventilation
1725.5.1 Pathophysiology
322.5.5 Controlled Mechanical Ventilation (CMV)
1735.5.2 Predisposition
332.5.6 Assisted/Controlled Mechanical Ventilation (A/C)
1745.5.3 Clinical Presentation
342.5.7 Synchronized Intermittent Mandatory Ventilation (SIMV)
1755.5.4 Complications
352.5.8 Continuous Positive Airway Pressure (CPAP)
1765.5.5 Treatment
362.5.9 Pressure Support Ventilation (PSV)
1775.6 Hypothermia
372.5.10 Airway Pressure Release Ventilation (APRV)
1785.6.1 Pathophysiology
382.6 Initiation of Mechanical Ventilation : 2.6.1 Criteria for Initiation of Mechanical Ventilation
1795.6.2 Predisposition
392.7 General Principles of Ventilator Management (See Also Table 2.4) : 2.7.1 Weaning From Mechanical Ventilation
1805.6.3 Clinical Presentation
402.8 Exercise
1815.6.4 Complications
41Chapter
1825.6.5 Treatment
423 The Basics of Critical Care
1835.7 Smoke Inhalation And Carbon Monoxide Poisoning
433.1 Ischemic Heart Disease: 3.1.1 Unstable Angina Pectoris
1845.7.1 Pathophysiology
443.2 Myocardial Infarction
1855.7.2 Predisposition
453.2.1 Definition
1865.7.3 Clinical Presentation
463.2.2 Pathophysiology
1875.7.4 Complications
473.2.3 Risk Factors
1885.7.5 Treatment
483.2.4 Clinical Presentation
1895.8 Scorpion Envenomation
493.2.5 Physical Findings
1905.8.1 Pathophysiology
503.2.6 Diagnostic Studies
1915.8.2 Predisposition
513.2.7 Treatment of Acute MI
1925.8.3 Clinical Presentation
523.2.8 Uncomplicated MI
1935.8.4 Complications
533.2.9 Complicated MI
1945.8.5 Treatment
543.2.10 IABP
1955.8.6 Prognosis
553.2.11 Other Complications Following MI
1965.9 Exercise
563.2.12 Conduction Disturbances Accompanying Acute MI
197Chapter
573.3 Cardiac Pacemakers
1986 Gastrointestinal Disorders
583.3.1 Definition
1996.1 Gastrointestinal Bleeding
593.3.2 Pacemaker Evaluation
2006.1.1 Classification
603.4 Congestive Heart Failure
2016.1.2 Etiology
613.4.1 Definition
2026.1.3 Diagnostic Evaluation
623.4.2 Etiology
2036.1.4 Initial ICU Management
633.4.3 Clinical Manifestations
2046.1.5 Specific Management of Selected Conditions
643.4.4 Physical Examination
2056.2 Acute Mesenteric Ischemia
653.4.5 Classification of CHF
2066.2.1 Definition
663.4.6 Chest X-Ray
2076.2.2 Epidemiology
673.4.7 Therapy
2086.2.3 Etiology
683.5 Cardiomyopathies
2096.2.4 Risk Factors for AMI
693.5.1 Dilated Congestive Cardiomyopathy
2106.2.5 Diagnostic Evaluation
703.5.2 Restrictive Cardiomyopathy
2116.2.6 Therapy
713.5.3 Hypertrophic Cardiomyopathy
2126.3 Fulminant Hepatic Failure And Encephalopathy
723.6 Myocarditis
2136.3.1 Definition
733.6.1 Etiology
2146.3.2 Etiology
743.6.2 Symptoms
2156.3.3 Diagnostic Evaluation
753.6.3 Physical Examination
2166.3.4 Complications of FHF
763.6.4 Therapy
2176.3.5 Management
773.7 Pericarditis
2186.4 Exercise
783.7.1 Etiology
219Chapter
793.7.2 Symptoms
2207 Hematologic Disorders
803.7.3 Physical Examination
2217.1 Anemia
813.7.4 Diagnostic Studies
2227.1.1 Definition
823.7.5 Treatment
2237.1.2 Etiology
833.7.6 Complications
2247.1.3 Diagnostic Evaluation
843.8 Valvular Heart Disease
2257.1.4 Therapy
853.8.1 Aortic Stenosis
2267.2 Leukopenia
863.8.2 Aortic Insufficiency
2277.2.1 Definitions
873.8.3 Mitral Stenosis
2287.2.2 Etiology
883.8.4 Mitral Regurgitation
2297.2.3 Diagnostic Evaluation
893.9 Aortic Dissection
2307.3 Thrombocytopenia
903.9.1 Definition
2317.3.1 Definition
913.9.2 Etiology
2327.3.2 Etiology
923.9.3 Classification
2337.3.3 Diagnostic Evaluation
933.9.4 Symptoms
2347.4 Anticoagulation And Fibrinolysis
943.9.5 Physical Findings
2357.4.1 Anticoagulation
953.9.6 Diagnostic Studies
2367.4.2 Fibrinolysis
963.9.7 Therapy
2377.5 Exercise
973.10 Exercise
238Chapter
98Chapter
2398 Infectious Diseases
994 Endocrinologic Disorders
2408.1 Pneumonia (Nosocomial)
1004.1 Adrenal Insufficiency
2418.1.1 Definition
1014.1.1 Definition
2428.1.2 Predisposing Factors
1024.1.2 Pathophysiology
2438.1.3 Etiologic Agents
1034.1.3 Etiology
2448.1.4 Clinical Manifestations
1044.1.4 Clinical Manifestations
2458.1.5 Diagnosis
1054.1.5 Associated Laboratory Abnormalities
2468.1.6 Treatment Options
1064.1.6 Diagnostic Evaluation
2478.1.7 Prevention
1074.1.7 Therapy
2488.2 Severe Adult Respiratory Syndrome (Sars)
1084.1.8 Complications
2498.3 Sepsis
1094.2 Diabetes Insipidus
2508.3.1 Definition
1104.2.1 Definitions
2518.3.2 Sepsis and Related Disorders
1114.2.2 Etiology
2528.3.3 Pathophysiology
1124.2.3 Clinical Manifestations
2538.3.4 Priorities in the Treatment of Sepsis
1134.2.4 Evaluation of Polyuria
2548.3.5 Prognosis
1144.2.5 Diagnostic Approach
2558.3.6 Activated Protein C
1154.2.6 F. Therapy
2568.4 Exercise
1164.3 Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH)
257Chapter
1174.3.1 Definition
2589 Allergic and Immunologic Emergencies
1184.3.2 Pathophysiology
2599.1 Anaphylaxis
1194.3.3 Etiology
2609.1.1 Definition
1204.3.4 Clinical Manifestations
2619.1.2 Etiology
1214.3.5 Diagnostic Evaluation
2629.1.3 Clinical Manifestations
1224.3.6 Differential Diagnosis
2639.1.4 Laboratory Findings
1234.3.7 Therapy
2649.1.5 Management
1244.3.8 Precautions Regarding Therapy
2659.1.6 Precentive Measures
1254.4 Diabetic Ketoacidosis and Hyperosmolar Nonketotic Coma
2669.2 Stevens-Johnson Syndrome (Erythema Multiforme)
1264.4.1 Definitions
2679.2.1 Definition
1274.4.2 Pathophysiology
2689.2.2 Etiology
1284.4.3 Etiology
2699.2.3 Clinical Manifestations
1294.4.4 Diagnostic Evaluation
2709.2.4 Laboratory Findings
1304.4.5 Management
2719.2.5 Management
1314.5 Tight Glycemic Control In The Icu
2729.3 Angioneurotic Laryngeal Edema
1324.6 Myxedema
2739.3.1 Definition
1334.6.1 Definition and Epidemiology
2749.3.2 Etiology
1344.6.2 Pathophysiology
2759.3.3 Clinical Manifestations
1354.6.3 Etiology
2769.3.4 Laboratory Findings
1364.6.4 Risk Factors
2779.3.5 Management
1374.6.5 Symptoms
2789.4 Exercise
1384.6.6 Diagnostic Evaluation
279Glossary
1394.6.7 Differential Diagnosis
280Appendix
1404.6.8 Therapy
281Index
1414.6.9 Complications
